×
Antibiotic Exposure and the Risk for Depression, Anxiety, or Psychosis: A Nested Case-Control Study PDF
$ 40.00
Antibiotic Exposure and the Risk for Depression, Anxiety, or Psychosis: A Nested Case-Control Study PDF quantity
$ 40.00
×
Impact of Cannabis and Other Drugs on Age at Onset of Psychosis PDF
$ 40.00
Impact of Cannabis and Other Drugs on Age at Onset of Psychosis PDF quantity
$ 40.00
×
Carbamazepine Augmentation for Schizophrenia: How Good Is the Evidence? PDF
$ 40.00
Carbamazepine Augmentation for Schizophrenia: How Good Is the Evidence? PDF quantity
$ 40.00
×
Divalproex Sodium for the Treatment of Conduct Disorder: A Randomized Controlled Clinical Trial PDF
$ 40.00
Divalproex Sodium for the Treatment of Conduct Disorder: A Randomized Controlled Clinical Trial PDF quantity
$ 40.00
×
Optimal Dosing With Risperidone: Updated Recommendations PDF
$ 40.00
Optimal Dosing With Risperidone: Updated Recommendations PDF quantity
$ 40.00
×
Cardiovascular Disease in Patients With Schizophrenia in Saskatchewan, Canada PDF
$ 40.00
Cardiovascular Disease in Patients With Schizophrenia in Saskatchewan, Canada PDF quantity
$ 40.00
×
A Double-Blind Study of Citalopram Versus Placebo in the Treatment of Compulsive Sexual Behaviors in Gay and Bisexual Men PDF
$ 40.00
A Double-Blind Study of Citalopram Versus Placebo in the Treatment of Compulsive Sexual Behaviors in Gay and Bisexual Men PDF quantity
$ 40.00
×
Antidepressant Drug Interaction in the Diagnosis of an Adrenal Tumor PDF
$ 40.00
Antidepressant Drug Interaction in the Diagnosis of an Adrenal Tumor PDF quantity
$ 40.00
×
Increased Risk of Cerebrovascular Adverse Events and Death in Elderly Demented Patients Treated With Atypical Antipsychotics: What's a Clinician to Do? PDF
$ 40.00
Increased Risk of Cerebrovascular Adverse Events and Death in Elderly Demented Patients Treated With Atypical Antipsychotics: What's a Clinician to Do? PDF quantity
$ 40.00
×
Pharmacoepidemiology: Recent Findings and Challenges for Child and Adolescent Psychopharmacology PDF
$ 40.00
Pharmacoepidemiology: Recent Findings and Challenges for Child and Adolescent Psychopharmacology PDF quantity
$ 40.00
×
Adverse Neuropsychiatric Reactions to Herbal and Over-the-Counter "Antidepressants." PDF
$ 40.00
Adverse Neuropsychiatric Reactions to Herbal and Over-the-Counter "Antidepressants." PDF quantity
$ 40.00
×
The Adverse Effect Profile and Efficacy of Divalproex Sodium Compared With Valproic Acid: A Pharmacoepidemiology Study PDF
$ 40.00
The Adverse Effect Profile and Efficacy of Divalproex Sodium Compared With Valproic Acid: A Pharmacoepidemiology Study PDF quantity
$ 40.00
×
Factors Associated With Temporal Priority in Comorbid Bipolar I Disorder and Alcohol Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF
$ 40.00
Factors Associated With Temporal Priority in Comorbid Bipolar I Disorder and Alcohol Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF quantity
$ 40.00
×
Positive Affect and Survival in Patients With Stable Coronary Heart Disease: Findings From the Heart and Soul Study PDF
$ 40.00
Positive Affect and Survival in Patients With Stable Coronary Heart Disease: Findings From the Heart and Soul Study PDF quantity
$ 40.00
×
Insight as a Predictor of the Outcome of First-Episode Nonaffective Psychosis in a Prospective Cohort Study in England PDF
$ 40.00
Insight as a Predictor of the Outcome of First-Episode Nonaffective Psychosis in a Prospective Cohort Study in England PDF quantity
$ 40.00
×
Prediction of Late-Onset Psychiatric Disorder in Survivors of Severe Injury: Findings of a Latent Transition Analysis PDF
$ 40.00
Prediction of Late-Onset Psychiatric Disorder in Survivors of Severe Injury: Findings of a Latent Transition Analysis PDF quantity
$ 40.00
×
Vaccine-Induced Psychosis as an Etiology to Consider in the Age of COVID-19 PDF
$ 40.00
Vaccine-Induced Psychosis as an Etiology to Consider in the Age of COVID-19 PDF quantity
$ 40.00
×
Divalproex Sodium Versus Olanzapine in the Treatment of Acute Mania in Bipolar Disorder: Health-Related Quality of Life and Medical Cost Outcomes PDF
$ 40.00
Divalproex Sodium Versus Olanzapine in the Treatment of Acute Mania in Bipolar Disorder: Health-Related Quality of Life and Medical Cost Outcomes PDF quantity
$ 40.00
×
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF
$ 40.00
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF quantity
$ 40.00
×
Major Depressive Disorder, Antidepressant Use, and Subsequent 2-Year Weight Change Patterns in the Netherlands Study of Depression and Anxiety PDF
$ 40.00
Major Depressive Disorder, Antidepressant Use, and Subsequent 2-Year Weight Change Patterns in the Netherlands Study of Depression and Anxiety PDF quantity
$ 40.00
×
How Do Clinicians Respond to Patients Who Miss Appointments? PDF
$ 40.00
How Do Clinicians Respond to Patients Who Miss Appointments? PDF quantity
$ 40.00
×
Commentary on “Catatonia and Competency to Stand Trial With Unique Response to Haloperidol” PDF
$ 40.00
Commentary on “Catatonia and Competency to Stand Trial With Unique Response to Haloperidol” PDF quantity
$ 40.00
×
Barriers and Pathways to Changing Smoking and Risky Drinking in Primary Care Patients With Chronic Conditions Who Failed to Respond to Brief Advice PDF
$ 40.00
Barriers and Pathways to Changing Smoking and Risky Drinking in Primary Care Patients With Chronic Conditions Who Failed to Respond to Brief Advice PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart